2,5- bis(1- aziridinyl)- 3,6- bis(2- methoxyethoxy)- 4- benzoquinone

structure

Also Known As:

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-2,5-cyclohexadiene-1,4-dione; 2,5-bis(aziridinyl)-3,6-bis(2-methoxyethoxy)quinone; 2,5-bis(methoxyethoxy)-3,6-bis(ethyleneimino)-p-benzoquinone; Bayer A 139

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azirines
    - Aziridines: 14
      - 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone: 2
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclohexanes: 3
        Cyclohexenes: 4
        2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone: 2
- Quinones: 434
  - Benzoquinones: 25
    - 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone: 2

Related Diseases

1.	Neoplasms (Cancer) 01/01/1960 - "[On the action of 2, 5-bis(2-methoxyethoxy)-3, 6-bis-ethylenimino-1, 4-benzoquinone (Bayer A 139) on the glycolysis of ascites tumor cells]." 07/01/1958 - "[Critical observations on therapy of malignancy with the cytostatic Bayer A 139 in otorhinolaryngological therapeutics]."
2.	Ascites 01/01/1960 - "[On the action of 2, 5-bis(2-methoxyethoxy)-3, 6-bis-ethylenimino-1, 4-benzoquinone (Bayer A 139) on the glycolysis of ascites tumor cells]."

Related Drugs and Biologics

1.	Cytostatic Agents

Related Therapies and Procedures

1.	Therapeutics